The missing link biomarker in cardiac testing

Welcome to CardiNor
– developing the missing link biomarker test for cardiovascular disease

CardiNor AS is a Norwegian biotech company recently established to handle the commercialization of Secretoneurin (SN), a new biomarker for cardiovascular disease (CVD).

Facts and figures

US cost on cardiovascular disease 3500 USD/sec.
One heart attac in US every 43 sec.

Latest news from CardiNor

CardiNor AS has achieved CE marking according to IVDD for the CardiNor Secretoneurin ELISA assay. We will now expand our distribution network globally and prepare for US market entry.

SN is the only biomarker shown to be associated with biological processes linked to cardiomyocyte handling and has been described as the “missing link biomarker” in cardiovascular disease risk assessment. Read more

Contact Us

Send us an email and we'll get back to you, asap.